4 completed, 1 terminated, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Terminated 1, Unknown 1 |
Follow napabucasin: new trials by email Literature Review of napabucasin trials Research Report on napabucasin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer Napabucasin, Fluorouracil, Leucovorin - Previously Treated Metastatic Colorectal Cancer | Phase 3 | Unknown | 1Globe Health Institute LLC | 668 | 2018-04-12 | 2019-06-18 |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma Napabucasin, Nab-paclitaxel, Gemcitabine - Carcinoma, Pancreatic Ductal | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 1134 | 2016-12-01 | 2023-11-15 |
| A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer Napabucasin, Paclitaxel - Carcinoma, Non-Small-Cell Lung | Phase 3 | Terminated | Sumitomo Pharma America, Inc. | 4 | 2016-11-01 | 2023-11-15 |
| A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer Napabucasin, Fluorouracil, Leucovorin - Colorectal Cancer | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 1253 | 2016-06-01 | 2023-11-15 |
| A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer BBI608, Paclitaxel, Placebo - Gastric Cancer, Gastroesophageal Junction Cancer | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 714 | 2014-10-01 | 2023-11-15 |
| BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma BBI608, Placebo, Best Supportive Care - Colorectal Carcinoma | Phase 3 | Completed | NCIC Clinical Trials Group | 282 | 2013-05-10 | 2023-08-28 |
Neoplasms (3) · Neoplasms by Site (3) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma (1) · Bronchial Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Pancreatic Ductal (1) · Colonic Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1)
Sumitomo Pharma America, Inc. (4) · 1Globe Health Institute LLC (1) · NCIC Clinical Trials Group (1)
Australia (4) · Canada (4) · China (4) · Japan (4) · United States (4) · Belgium (3) · Czechia (3) · France (3) · Germany (3) · Italy (3) · South Korea (3) · Spain (3) · Israel (2) · Netherlands (2) · Poland (2)
Derek Jonker (1)
2014 (1), 2016 (1)